Asian Spectator

Men's Weekly

.

ERBITUX(R) Approved for First-line Use in China in Patients W...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
DARMSTADT, Germany, Mar. 2, 2020 /PRNewswire-AsiaNet/-- Not intended for UK-based media- Approval is for ERBITUX(R) in combination with platinum-based therapy with fluorouracil for the first-line treatment of R/M SCCHN- Pivotal Phase III study shows significant improvements with ERBITUX(R) in c...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

The Role of Family Lawyers in Protecting Children’s Interests

When family relationships break down, decisions about children can become tense quickly. In these matters, the focus is meant to stay on what supports a child’s wellbeing, even when adults feel hurt...

Buying Managed IT Services in Australia (Without Paying for Surprises)

Managed IT usually becomes a serious conversation when interruptions start affecting delivery. For most Australian businesses in the 7–100 staff range, that shift happens quietly.  For example, clo...

Ramadan jadi peluang ‘brand’ melejit: Intip strategi Marjan, Promag, dan sarung Atlas

● Ramadan secara tradisi mendorong terjadinya peningkatan konsumsi masyarakat yang cukup signifikan.● Karena itu, Ramadan kerap dijadikan momen untuk meningkatkan omzet bagi brand.● ...